🎯 check Larotrectinib (LOXO-101) product page
Larotrectinib is a potent ATP-competitive TRK inhibitor. It affects ERK/AKT signaling by blocking TRK, inhibiting tumor growth.
Larotrectinib (LOXO-101): Mechanism of Action
Larotrectinib (LOXO-101) MOA：Targeting TRK/MAPK Pathway for NTRK Fusion-Positive Solid Tumors
Jump to
- Larotrectinib (LOXO-101) Clinical Trials
- Larotrectinib (LOXO-101): Selectivity & Specificity
- Larotrectinib (LOXO-101) Working Concentration | Cell Culture | Treatment
- Larotrectinib (LOXO-101) Solubility in DMSO
- Larotrectinib (LOXO-101) Stock Solution
- Larotrectinib (LOXO-101) Storage
- Larotrectinib (LOXO-101) Stability
- Larotrectinib (LOXO-101) Combination Database
- Larotrectinib (LOXO-101) Molecular Weight
- Larotrectinib (LOXO-101) SMILES
- Larotrectinib (LOXO-101) CAS Number
- Larotrectinib (LOXO-101) Chemical Structure (2D and 3D)
- Larotrectinib (LOXO-101) IC50 for Cell-based and Cell-free Assays
- Larotrectinib (LOXO-101) Cayman (27056)? Try a better option.
- Larotrectinib (LOXO-101) APExBIO (A4684)? Try a better option.
- Larotrectinib (LOXO-101) MedChemExpress (HY-12866)? Try a better option.
- Larotrectinib (LOXO-101) Sigma (AMBH93D52F73)? Try a better option.
- Larotrectinib (LOXO-101) SDS｜MSDS